6-112350007-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001013734.3(RFPL4B):c.299A>C(p.Asp100Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000245 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001013734.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFPL4B | ENST00000441065.3 | c.299A>C | p.Asp100Ala | missense_variant | Exon 3 of 3 | 2 | NM_001013734.3 | ENSP00000423391.1 | ||
ENSG00000281613 | ENST00000587816.2 | c.299A>C | p.Asp100Ala | missense_variant | Exon 5 of 5 | 5 | ENSP00000487146.1 | |||
ENSG00000281613 | ENST00000585611.5 | c.*89A>C | downstream_gene_variant | 5 | ENSP00000486440.1 | |||||
ENSG00000281613 | ENST00000590673.5 | c.*193A>C | downstream_gene_variant | 5 | ENSP00000486934.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000223 AC: 56AN: 251432Hom.: 1 AF XY: 0.000206 AC XY: 28AN XY: 135892
GnomAD4 exome AF: 0.000250 AC: 365AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000235 AC XY: 171AN XY: 727248
GnomAD4 genome AF: 0.000204 AC: 31AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.299A>C (p.D100A) alteration is located in exon 3 (coding exon 1) of the RFPL4B gene. This alteration results from a A to C substitution at nucleotide position 299, causing the aspartic acid (D) at amino acid position 100 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at